A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Molecular Graphics and Modelling

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jmgm.2015.11.004PMID 26724452
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Design, synthesis, chemical and biological evaluation of brain targeted alkylating agent using reversible redox prodrug approach

  2017cited by this paper
• Sphingosine 1-phosphate signaling at the blood-brain barrier.

  2015cited by this paper
• Sphingosine-1-phosphate metabolism: A structural perspective

  2015cited by this paper
• Orally active 7-substituted (4-benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as active-site inhibitors of sphingosine 1-phosphate lyase for the treatment of multiple sclerosis.

  2014cited by this paper
• Deficiency of Sphingosine-1-phosphate Lyase Impairs Lysosomal Metabolism of the Amyloid Precursor Protein*

  2014cited by this paper
• Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E₂ synthase-1 enzyme (mPGES-1).

  2014cited by this paper
• The role of ligand efficiency metrics in drug discovery

  2014cited by this paper
• The first sphingosine 1-phosphate lyase inhibitors against multiple sclerosis: a successful drug discovery tale.

  2014cited by this paper
• Partial Deficiency of Sphingosine-1-Phosphate Lyase Confers Protection in Experimental Autoimmune Encephalomyelitis

  2013cited by this paper
• The holistic integration of virtual screening in drug discovery.

  2013cited by this paper
• A comparison of in vitro ADME properties and pharmacokinetics of azithromycin and selected 15-membered ring macrolides in rodents

  2013cited by this paper
• Inhibition of sphingosine-1-phosphate lyase rescues sphingosine kinase-1-knockout phenotype following murine cardiac arrest.

  2013cited by this paper
• ZINC: A Free Tool to Discover Chemistry for Biology

  2012cited by this paper
• Combining pharmacophore, docking and substructure search approaches to identify and optimize novel B-RafV600E inhibitors.

  2012cited by this paper
• Integrating structure-based and ligand-based approaches for computational drug design.

  2011cited by this paper
• Kinetics, in silico docking, molecular dynamics, and MM‐GBSA binding studies on prototype indirubins, KT5720, and staurosporine as phosphorylase kinase ATP‐binding site inhibitors: The role of water molecules examined

  2011cited by this paper
• ConfGen: A Conformational Search Method for Efficient Generation of Bioactive Conformers

  2010cited by this paper
• Large-Scale Systematic Analysis of 2D Fingerprint Methods and Parameters to Improve Virtual Screening Enrichments

  2010cited by this paper
• Drug-like Bioactive Structures and Conformational Coverage with the LigPrep/ConfGen Suite: Comparison to Programs MOE and Catalyst

  2010cited by this paper
• Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis

  2010cited by this paper
• Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function.

  2010cited by this paper
• Ligand docking and binding site analysis with PyMOL and Autodock/Vina

  2010cited by this paper
• Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime (LX2931) and (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932).

  2010cited by this paper
• Analysis and comparison of 2D fingerprints: insights into database screening performance using eight fingerprint methods

  2010cited by this paper
• Synthesis, physicochemical properties and antimicrobial activity of some new benzimidazole derivatives.

  2009cited by this paper
• Incomplete Inhibition of Sphingosine 1-Phosphate Lyase Modulates Immune System Function yet Prevents Early Lethality and Non-Lymphoid Lesions

  2009cited by this paper
• Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate

  2009cited by this paper
• Bioactive sphingolipids: metabolism and function This work was supported by National Institutes of Health Grants GM-43825 and CA-87584. Published, JLR Papers in Press, November 17, 2008.

  2009cited by this paper
• Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders.

  2009cited by this paper
• Benchmarking the reliability of QikProp. Correlation between experimental and predicted values

  2008cited by this paper
• Sphingolipid metabolizing enzymes as novel therapeutic targets.

  2008cited by this paper
• The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.

  2007cited by this paper
• Ligand efficiency indices for effective drug discovery

  2007cited by this paper
• Finding a way out: lymphocyte egress from lymphoid organs

  2007cited by this paper
• PHASE: A Novel Approach to Pharmacophore Modeling and 3D Database Searching

  2006cited by this paper
• Novel procedure for modeling ligand/receptor induced fit effects.

  2006cited by this paper
• Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer

  2006cited by this paper
• Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents.

  2005cited by this paper
• Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients

  2005cited by this paper
• Ligand efficiency indices as guideposts for drug discovery.

  2005cited by this paper
• Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone

  2004cited by this paper
• Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening.

  2004cited by this paper
• Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

  2004cited by this paper
• Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1

  2004cited by this paper
• Sphingosine-1-phosphate: an enigmatic signalling lipid

  2003cited by this paper
• Predicting Blood–Brain Barrier Partitioning of Organic Molecules Using Membrane–Interaction QSAR Analysis

  2002cited by this paper
• Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

  2002cited by this paper
• Crystal structure and functional analysis of the HERG potassium channel N terminus: a eukaryotic PAS domain.

  1998cited by this paper
• Emigration of mature T cells from the thymus is inhibited by the imidazole‐based compound 2‐acetyl‐4‐tetrahydroxybutylimidazole

  1998cited by this paper

• Exploring curcumin and its synthetic derivatives against key genes for therapeutics of rheumatoid arthritis in the Indian population: a computational approach

  2026cites this paper
• In Silico Analysis of Anti-Cancer Activity of Exopolysaccharide Isolated from Novel Pseudolagarobasidium acaciicola through Mass Production, Gel Permeation Separation, and Compositional Analysis.

  2025cites this paper
• Chitosan-ZnS Nanocomposite Hydrogel Beads to Combat Multi-Drug-Resistant Pathogens

  2025cites this paper
• Bioactivity‐Guided Isolation of Cytotoxic Compounds From Curcuma caesia: In Vitro and In Silico Investigation for Oral Cancer

  2025cites this paper
• Impact of bio-computational tools for early detection of competent drug possibilities from Zingiber officinale Roscoe against adiponectin protein of type 2 diabetes mellitus and cardiovascular disease

  2025cites this paper
• Synthesis and Assessment of Antibacterial Potential of Metal Chelated (1‐Vinyl‐3‐Alkylimidazolium‐Styrene‐Divinyl Benzene) Co‐Polymers: In Vitro and In Silico Analysis

  2025cites this paper
• Inhibiting sphingosine 1-phosphate lyase: From efficacy to mechanism.

  2024cites this paper
• Evaluation of 1-vinyl-3-alkyl imidazolium-based ionic liquid monomers towards antibacterial activity: An in-silico & in-vitro study

  2024cites this paper
• Effect of environmentally friendly reverse osmosis scale inhibitors on inorganic calcium carbonate scale

  2024cites this paper
• Docking and molecular dynamic simulations of Mithramycin-A and Tolfenamic acid against Sp1 and survivin.

  2024cites this paper
• Alpha mangostin inhibits proliferation, migration, and invasion of human breast cancer cells via STAT3 inhibition

  2023cites this paper
• Interaction Between 2‐Methylimidazole and 1‐Butanol/1‐Octanol: Thermophysical and Computational Studies

  2023cites this paper
• Diaryl ether derivative inhibits GPX4 expression levels to induce ferroptosis in thyroid cancer cells

  2023cites this paper
• Sphingosine 1-Phosphate Lyase in the Developing and Injured Nervous System: a Dichotomy?

  2023cites this paper
• Identification of rare nsSNPs in fragile histidine triad (FHIT) gene to explore its correlation with oral cancer: An in-silico approach

  2023cites this paper
• Theoretical Studies for the Discovery of Potential Sucrase-Isomaltase Inhibitors from Maize Silk Phytochemicals: An Approach to Treatment of Type 2 Diabetes

  2023cites this paper
• In Silico Analysis Determining the Binding Interactions of NAD(P)H: Quinone Oxidoreductase 1 and Resveratrol via Docking and Molecular Dynamic Simulations

  2023cites this paper
• Biocomputational Assessment of Natural Compounds as a Potent Inhibitor to Quorum Sensors in Ralstonia solanacearum

  2022cites this paper
• In-silico and in-vitro investigation of STAT3-PIM1 heterodimeric complex: Its mechanism and inhibition by curcumin for cancer therapeutics.

  2022cites this paper
• The Oxidative Process of Acarbose, Maysin, and Luteolin with Maltase-Glucoamylase: Molecular Docking and Molecular Dynamics Study

  2021cites this paper
• Computational identification of 2,4-disubstituted amino-pyrimidines as L858R/T790M-EGFR double mutant inhibitors using pharmacophore mapping, molecular docking, binding free energy calculation, DFT study and molecular dynamic simulation

  2021cites this paper
• Virtual screening in drug discovery: a precious tool for a still-demanding challenge

  2020cites this paper
• Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya

  2019cites this paper
• Investigation of MI-2 analogues as MALT1 inhibitors to treat of diffuse large B-Cell lymphoma through combined molecular dynamics simulation, molecular docking and QSAR techniques and design of new inhibitors

  2019cites this paper
• Inflammatory response and its relation to sphingolipid metabolism proteins: Chaperones as potential indirect anti-inflammatory agents.

  2019cites this paper
• Rational approach to identify newer caspase-1 inhibitors using pharmacophore based virtual screening, docking and molecular dynamic simulation studies.

  2018cites this paper
• Structure-based design, synthesis and evaluation of 2,4-diaminopyrimidine derivatives as novel caspase-1 inhibitors.

  2018cites this paper
• In Silico Studies in Drug Research Against Neurodegenerative Diseases

  2017cites this paper
• Investigation of novel pharmacological chaperones for Gaucher Disease.

  2017cites this paper
• Synthesis of 2-Vinyl sphingolipids as S1PL inhibitors

  2017cites this paper
• Sphingosine kinase 1 (SK1) allosteric inhibitors that target the dimerization site

  2017cites this paper
• Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential Risks

  2016cites this paper
• Bacterial versus human sphingosine-1-phosphate lyase (S1PL) in the design of potential S1PL inhibitors.

  2016cites this paper